Nezu Biotech

Nezu Biotech GmbH is an early-stage AI-driven biotechnology and bioinformatics company founded in January 2025 as a spin-off from the University of Heidelberg. Headquartered in Heidelberg, Germany, the company specializes in developing advanced in-silico platforms to predict toxicity, ADME (absorption, distribution, metabolism, and excretion), and skin sensitization profiles of small molecules. Its core commercial offerings include SkinReact™, ToxSpotter™, and ADME Hero™, which are designed to dramatically reduce the cost and timeline of preclinical drug discovery and chemical safety testing. Originally incubated within the European Space Agency Business Incubation Centre (ESA-BIC) to support space medicine and future crewed missions, Nezu Biotech applies these space-grade standards to de-risk therapeutic candidates for terrestrial healthcare applications.